IL140033A0 - Novel methods for rescue of rna viruses - Google Patents

Novel methods for rescue of rna viruses

Info

Publication number
IL140033A0
IL140033A0 IL14003399A IL14003399A IL140033A0 IL 140033 A0 IL140033 A0 IL 140033A0 IL 14003399 A IL14003399 A IL 14003399A IL 14003399 A IL14003399 A IL 14003399A IL 140033 A0 IL140033 A0 IL 140033A0
Authority
IL
Israel
Prior art keywords
virus
recombinant virus
producing
viruses
mononegavirales
Prior art date
Application number
IL14003399A
Other languages
English (en)
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL140033A0 publication Critical patent/IL140033A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/001Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/60Vector systems having a special element relevant for transcription from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/80Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85Vector systems having a special element relevant for transcription from vertebrates mammalian
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/20Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL14003399A 1998-06-03 1999-06-03 Novel methods for rescue of rna viruses IL140033A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8780098P 1998-06-03 1998-06-03
PCT/US1999/012292 WO1999063064A1 (en) 1998-06-03 1999-06-03 Novel methods for rescue of rna viruses

Publications (1)

Publication Number Publication Date
IL140033A0 true IL140033A0 (en) 2002-02-10

Family

ID=22207342

Family Applications (3)

Application Number Title Priority Date Filing Date
IL14003399A IL140033A0 (en) 1998-06-03 1999-06-03 Novel methods for rescue of rna viruses
IL140033A IL140033A (en) 1998-06-03 2000-12-01 Method of producing non-segmented, negative-sense, single-stranded rna viruses
IL182512A IL182512A (en) 1998-06-03 2007-04-12 Method for the production of recombinant viruses of the MONONEGAVIRALES type, a recombinant virus produced by the method and a compound containing it

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL140033A IL140033A (en) 1998-06-03 2000-12-01 Method of producing non-segmented, negative-sense, single-stranded rna viruses
IL182512A IL182512A (en) 1998-06-03 2007-04-12 Method for the production of recombinant viruses of the MONONEGAVIRALES type, a recombinant virus produced by the method and a compound containing it

Country Status (14)

Country Link
EP (2) EP1995310B1 (de)
JP (1) JP4625915B2 (de)
KR (2) KR100619319B1 (de)
CN (1) CN1196780C (de)
AT (1) ATE499438T1 (de)
AU (1) AU761234B2 (de)
BR (1) BR9910929A (de)
CA (1) CA2333313C (de)
DE (1) DE69943215D1 (de)
DK (1) DK1090108T3 (de)
ES (1) ES2358315T3 (de)
IL (3) IL140033A0 (de)
MX (1) MX228492B (de)
WO (1) WO1999063064A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7465574B2 (en) 1994-09-30 2008-12-16 Medimmune, Llc Recombinant RSV virus expression systems and vaccines
US6830748B1 (en) 1997-09-26 2004-12-14 Medimmune Vaccines, Inc. Recombinant RSV virus expression systems and vaccines
US6495360B1 (en) * 1999-05-28 2002-12-17 Photogen, Inc. Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
US7361496B1 (en) 2000-08-02 2008-04-22 Wyeth Rescue of mumps virus from cDNA
PT1375512E (pt) * 2002-06-20 2009-09-23 Pasteur Institut Adnc infeccioso de uma estirpe de vacina aprovada do vírus do sarampo. utilização de composições imunogénicas
BRPI0411247A (pt) * 2003-06-09 2006-07-25 Wyeth Corp processo melhorado para a recuperação de vìrus de rna de filamento negativo não segmentado partindo do cdna
EA023811B1 (ru) 2009-10-20 2016-07-29 Новартис Аг Способ получения вируса с использованием конструкции, кодирующей вирусную рнк
WO2013074501A1 (en) 2011-11-14 2013-05-23 Crucell Holland B.V. Heterologous prime-boost immunization using measles virus-based vaccines
CN102807989B (zh) * 2012-08-01 2014-04-23 中国人民解放军军事医学科学院军事兽医研究所 犬科和/或猫科动物疫病重组活载体疫苗的制备方法
JP2018510642A (ja) * 2015-03-27 2018-04-19 カディラ ヘルスケア リミティド 組換え流行性耳下腺炎ウイルスJeryl Lynn2系ワクチン
CN105039388B (zh) * 2015-06-30 2019-06-18 浙江大学 重组单链负义植物病毒侵染性克隆构建方法及质粒和病毒
CN107058359B (zh) * 2017-04-14 2019-08-13 北京交通大学 一种抗呼吸道合胞病毒药物的高通量筛选方法和应用
US12487152B2 (en) 2017-05-09 2025-12-02 Ultragenyx Pharmaceutical Inc. Scalable method for producing transfection reagents
CN111849927B (zh) * 2020-06-28 2022-07-08 浙江大学 高效产生重组不分节段负义rna病毒的方法及重组病毒
WO2025072889A1 (en) * 2023-09-28 2025-04-03 E & E Bioclub Llc Helper-free rescue system for negative-strand rna viruses
CN117625688B (zh) * 2024-01-26 2024-04-30 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) B亚型禽偏肺病毒反向遗传操作系统及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE161188T1 (de) * 1989-02-14 1998-01-15 Massachusetts Inst Technology Hemmung der transformation der zellen mit erhöhter purin-metabolischer enzymaktivität
KR100242671B1 (ko) * 1991-03-07 2000-03-02 고돈 에릭 유전학적으로 처리한 백신 균주
JPH06237773A (ja) * 1992-12-22 1994-08-30 Tonen Corp ポックスウイルスのa型封入体(ati)プロモーター及び前期プロモーターを含んで成る外来遺伝子発現ベクター
EP0780475B2 (de) 1995-08-09 2006-07-19 SCHWEIZ. SERUM- & IMPFINSTITUT BERN Verfahren zur Herstellung von infektiösen minussträngigen RNA-Viren
WO1997012032A1 (en) * 1995-09-27 1997-04-03 The Government Of The United States Of America, As Represented By The Department Of Health And Human Services Production of infectious respiratory syncytial virus from cloned nucleotide sequences
EP0932684A2 (de) * 1996-09-27 1999-08-04 American Cyanamid Company Mutationen in der genomischen 3'promoterregion und im polymerasegen, die für die attenuierung von viren der ordnung mononegavirales verantwortlich sind
US5871803A (en) 1997-05-30 1999-02-16 Campbell Soup Company Salt flavor enhancing compositions, food products including such compositions, and methods for preparing such products

Also Published As

Publication number Publication date
CA2333313A1 (en) 1999-12-09
CN1303426A (zh) 2001-07-11
JP4625915B2 (ja) 2011-02-02
MXPA00011420A (es) 2001-04-01
ATE499438T1 (de) 2011-03-15
IL182512A (en) 2012-07-31
KR20010052498A (ko) 2001-06-25
CA2333313C (en) 2011-11-08
WO1999063064A1 (en) 1999-12-09
EP1090108A1 (de) 2001-04-11
AU761234B2 (en) 2003-05-29
BR9910929A (pt) 2001-02-20
ES2358315T3 (es) 2011-05-09
EP1995310B1 (de) 2013-04-24
KR20060021943A (ko) 2006-03-08
KR100579662B1 (ko) 2006-05-12
CN1196780C (zh) 2005-04-13
EP1090108B1 (de) 2011-02-23
MX228492B (es) 2005-06-14
DK1090108T3 (da) 2011-04-26
IL182512A0 (en) 2007-09-20
EP1995310A1 (de) 2008-11-26
AU4414499A (en) 1999-12-20
JP2002517189A (ja) 2002-06-18
IL140033A (en) 2010-05-17
KR100619319B1 (ko) 2006-09-06
DE69943215D1 (de) 2011-04-07

Similar Documents

Publication Publication Date Title
IL182512A0 (en) Method for producing recombinant viruses of the mononegavirales order
Lopez et al. The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules
Römer-Oberdörfer et al. Generation of recombinant lentogenic Newcastle disease virus from cDNA
Buchholz et al. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter
US5789229A (en) Stranded RNA virus particles
Krishnamurthy et al. Recovery of a virulent strain of Newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation
Kolakofsky et al. Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited
Wang et al. The exceptionally large genome of Hendra virus: support for creation of a new genus within the family Paramyxoviridae
Tokusumi et al. Recombinant Sendai viruses expressing different levels of a foreign reporter gene
Durbin et al. Minimum protein requirements for transcription and RNA replication of a minigenome of human parainfluenza virus type 3 and evaluation of the rule of six
Haffar et al. The matrix protein gene sequence analysis reveals close relationship between peste des petits ruminants virus (PPRV) and dolphin morbillivirus
EP1211318A4 (de) Paramyxoviren, die modifizierte transkriptionsstart-sequenzen enthalten.
DK0846181T4 (da) cDNA svarende til antigenomet af ikke-segmenterede negativ-streng-virus og fremgangsmåde til fremstilling af sådanne virus der koder for yderligere antigent aktive proteiner
KR19990063811A (ko) 클론된 뉴클레오타이드 서열로부터 감염성 호흡장애 바이러스의생산 방법
JP2009529861A (ja) 鳥インフルエンザウイルスのh5ヘマグルチニンを発現する組み換えニューキャッスル病ウイルス
WO2004113517A3 (en) IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA
Meyer et al. A novel type of defective viral genome suggests a unique strategy to establish and maintain persistent lymphocytic choriomeningitis virus infections
JP2002541798A5 (de)
Kato et al. Sendai virus gene start signals are not equivalent in reinitiation capacity: moderation at the fusion protein gene
Okazaki et al. Molecular cloning and sequence analysis of the mumps virus gene encoding the L protein and the trailer sequence
Coquelet et al. Trypanosoma brucei: enrichment by UV of intergenic transcripts from the variable surface glycoprotein gene expression site
Berry-Lowe The chloroplast glutamate tRNA gene required for δ-aminolevulinate synthesis
Sánchez et al. Conserved structures among the nucleocapsid proteins of the paramyxoviridae: complete nucleotide sequence of human parainfluenza virus type 3 NP mRNA
Patterson et al. Multiple leader RNAs and messenger RNAs are transcribed from the La Crosse virus small genome segment
Luk et al. Complete nucleotide sequence of the matrix protein mRNA and three intergenic junctions of human parainfluenza virus type 3